Sort
15,842 grants matching “pancreatic cancer”
Genetic progression of pancreatic mucinous cystic neoplasms to invasive carcinoma
$369,582Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell System
$369,554Rajib Saha · University Of Nebraska Lincoln · R35 · FY2021 · GM
Comprehensive analysis and mitigation of the clinical effects of delineation and geometric uncertainties in conformal radiation therapy
$369,431Jeffrey V Siebers · University Of Virginia · R01 · FY2021 · CA
Identifying Molecular Drivers of Cellular Plasticity in Pancreatic Cancer
$369,431Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2020 · CA
Identifying Molecular Drivers of Cellular Plasticity in Pancreatic Cancer
$369,431Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2021 · CA
Dissecting new mechanisms of lysosome quality control in health and disease
$369,431Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2025 · CA
Dissecting new mechanisms of lysosome quality control in health and disease
$369,431Rushika Miriam Perera · University Of California, San Francisco · R01 · FY2021 · CA
Comprehensive analysis and mitigation of the clinical effects of delineation and geometric uncertainties in conformal radiation therapy
$369,431Jeffrey V Siebers · University Of Virginia · R01 · FY2020 · CA
Instrumentation for Creating Biological Stents and Occlusions
$369,350Fred Sterzer · Mmtc, Inc. · R44 · FY2010 · RR
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$369,337Tracy L McGaha · University Health Network · R01 · FY2022 · CA
Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer
$369,245Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R37 · FY2020 · CA
Biological Activity of Ras Oncogenes
$369,223Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Lipid storage and catabolism as drivers of metastatic invasion
$369,203Gina Lynn Razidlo · Mayo Clinic Rochester · R01 · FY2023 · CA
Lipid storage and catabolism as drivers of metastatic invasion
$369,203Gina Lynn Razidlo · Mayo Clinic Rochester · R01 · FY2025 · CA
Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticles
$369,115Lily Yang · Emory University · R01 · FY2019 · CA
Surgical Studies of Pancreatic Stem Cells
$369,037Johns Hopkins University · R01 · FY2004 · DK
Improved Staging of Pancreatic Cancer
$369,031Ralph Weissleder · Dana-Farber Cancer Inst · P50 · FY2007 · CA
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
$368,628Chrystal Mary Paulos · Emory University · R01 · FY2020 · CA
Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy
$368,579Kun Cheng · University Of Missouri Kansas City · R01 · FY2023 · CA
ATDC Function in Human Pancreatic Adenocarcinoma
$368,422Diane M Simeone · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
$368,346Yi-Chieh Nancy Du · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells
$368,288Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2018 · CA
Targeting aberrant circadian regulator in advanced prostate cancer
$368,288Hongwu Chen · University Of California At Davis · R01 · FY2025 · CA
Targeting macrophages for immunotherapy in pancreatic cancer
$368,288Gregory L Beatty · University Of Pennsylvania · R01 · FY2017 · CA